Difference between revisions of "DZI20-203"

From MGH Learn Pathology
(Edited automatically from page learn:wsidashboard.)
(Updating subject, access, and performer)
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{dziOrderStudySet
+
{{ServiceRequest
|order_date=October 16, 2020 07:01:52 PM
+
|intent=order
|user=Aja51
+
|category=409073007
|class_name=Study Set
+
|priority=routine
|status=Submitted
+
|orderDetail=order
|qc=yes
+
|locationCode=learn
|qcuser=Aja51
+
|code=study
|qctime=Nov 02, 2020 22:10:36
+
|requisition=Frozen Conference
|collection_name=Pulmonary Pathology
+
|supportingInfo=Pulmonary Pathology
|class_type=Frozen Conference
+
|reasonCode=HNG PULM
|collection_topic=HNG PULM
+
|subject=MGH
|requested_by=HNG
+
|performer=YPH1
|restrict_access=Public
+
|authoredOn=October 16, 2020 07:01:52 PM
 +
|requester=Aja51
 +
|access=public
 +
}}
 +
{{status
 +
|status=completed
 +
|authoredOn=March 09, 2022 01:48:36 PM
 +
|requester=Si787
 +
|identifier=DZI20-203
 
}}
 
}}

Latest revision as of 15:17, June 21, 2022


Request type Study
Subspecialty Pulmonary Pathology
Set Frozen Conference
Topic HNG PULM
Presenter Hung, Yin P.,MD, PhD


Toggle columns: Diagnosis

Case Clinical history Requester Diagnosis
Case Clinical history Requester Diagnosis

Case 1


81 yo M with endobronchial mass Mjf79 FX1+level) Calc f/o bronchus; FX2) bone bone marrow cartilage. Query hamartoma vs heterotopic ossification final: hamartoma

Case 2


76 yo M RUL lung nodule Mjf79 Lymphocytes plasma cells and spindle cells. Infection vs IMT. Negative for carcinoma Final: fibroinflammatory changes and bronchiectasis with necrosis palisading granulomas and rare giant cells

Case 3


73 yo M with RLL mass Mjf79 adenocarcinoma w/ mucinous features Final: invasive mucinous adenocarcinoma

Case 4


77 yo M with RML mass Mjf79 metastatic RCC final: metastatic RCC

Case 5


74 yo F with RLL mass Mjf79 FX1) adenocarcinoma with lepidic acinar and papillary patterns. FX3)Paranchymal LN = granulomatous inflammation in a nodular pattern Final: adenocarcinoma (50% lepidic 40% acinar 10% papillary). Lymph node: granulomatous inflammation

Case 6


74 yo M with 2 RUL masses identified grossly. Frozens taken: FX1: Parenchymal margin FX1A: Mass #1 FX2B: Mass #2 (subpleural) Mjf79 FX1: Margin negative FX1A: SCC. FX1B: fibroelastotic scarring Final: SCC keratinizing. Prominent subpleural fibroelastotic scarring which may represent prominent apical cap.

Case 7


73 yo M with h/o PDAC now with lung nodule LLL Mjf79 fibrosis CI and collections of histiocytes. No tumor seen. Final: fibroinflammatory changes with organization and focal cavity formation

Case 8


52 yo F with RUL mass Mjf79 adenocarcinoma final: adenocarcinoma (acinar mod 90% lepidic 10%)

Case 9


50 yo F with hilar adenopathy Mjf79 non-necrotizing granulomas in one lymph node and the other extensively hyalinized. Final: non-necrotizing granulomas c/w sarcoid in the appropriate clinical context

Case 10


63 yo M with a RML nodule Mjf79 mucinous epithelial proliferation favor ciliated mucondoular papillary tumor final: ciliated mucondoular papillary tumor

Case 11


57 yo M with lung mass RLL Mjf79 epithelial neoplasm favor carcinoid. final: carcinoid